How Jim Molan voted compared to someone who believes that terminally ill people should be able to access medicinal cannabis products

Division Jim Molan Supporters vote Division outcome

14th Nov 2019, 12:02 PM – Senate Committees - Community Affairs References Committee - Reference

Show detail

The majority voted in favour of a motion introduced by Victorian Senator Richard Di Natale (Greens), which means the matter will be referred to a Committee.

You can follow the inquiry on the Committee website.

Motion text

That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2020:

The current barriers to patient access to medicinal cannabis in Australia, including:

(a) the appropriateness of the current regulatory regime through the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS), Authorised Prescriber Scheme and clinical trials;

(b) the suitability of the Pharmaceutical Benefits Scheme for subsidising patient access to medicinal cannabis products;

(c) the interaction between state and territory authorities and the Commonwealth, including overlap and variation between state and territory schemes;

(d) Australia's regulatory regime in comparison to international best practice models for medicinal cannabis regulation and patient access;

(e) the availability of training for doctors in the current TGA regulatory regime for prescribing medicinal cannabis to their patients;

(f) the education of doctors in the Endogenous Cannabinoid System (ECS), and the appropriateness of medicinal cannabis treatments for various indications;

(g) sources of information for doctors about uses of medicinal cannabis and how these might be improved and widened;

(h) delays in access, and the practice of product substitution, due to importation of medicinal cannabis and the shortage of Australian manufactured medicinal cannabis products;

(i) the current status of the domestic regulated medicinal cannabis industry;

(j) the impacts on the mental and physical wellbeing of those patients struggling to access medicinal cannabis through Australia's regulatory regime;

(k) the particular barriers for those in rural and remote areas in accessing medicinal cannabis legally;

(l) the significant financial barriers to accessing medicinal cannabis treatment;

(m) the number of Australian patients continuing to rely on unregulated supply of medicinal cannabis due to access barriers and the impacts associated with that; and

(n) any related matters.

absent Yes Passed by a small majority

How "never voted" is worked out

Normally a person's votes count towards a score which is used to work out a simple phrase to summarise their position on a policy. However in this case Jim Molan was absent during all divisions for this policy. So, it's impossible to say anything concrete other than that they have "never voted" on this policy.